Cargando…
Death Receptors in Cancer Therapy
Cell death, or apoptosis, plays an important role in biological processes and disease and offers special opportunities to develop new therapies for cancer, autoimmune disease, stroke, heart attack, and Alzheimer's disease. In Death Receptors in Cancer Therapy, leading physician-scientists and b...
| Clasificación: | Libro Electrónico |
|---|---|
| Autor Corporativo: | |
| Otros Autores: | |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
Totowa, NJ :
Humana Press : Imprint: Humana,
2005.
|
| Edición: | 1st ed. 2005. |
| Colección: | Cancer Drug Discovery and Development,
|
| Temas: | |
| Acceso en línea: | Texto Completo |
Tabla de Contenidos:
- Mammalian Cell Death Pathways
- Resistance to Apoptosis in Cancer Therapy
- Structures of TNF Receptors and Their Interactions With Ligands
- Death Receptor Signaling in Embryonic Ectodermal Development
- Adaptor Proteins in Death Receptor Signaling
- Caspase Activation by the Extrinsic Pathway
- Death Signaling and Therapeutic Applications of TRAIL
- Death Receptor Mutations
- Regulation of Death Receptors
- Regulation of Trail Receptor Expression in Human Melanoma
- Regulation of Death Receptors by Synthetic Retinoids
- Role of p53 in Regulation of Death Receptors
- Proapoptotic Gene Silencing Via Methylation in Human Tumors
- Regulation of Death Receptor-Induced Apoptosis by NF-?B and Interferon Signaling Pathways
- TRAIL in Cancer Therapy
- Expression and Regulation of Death Receptors in Multiple Myeloma and Prostate Carcinoma
- Regulation of TRAIL-Induced Apoptosis by Transcriptional Factors
- Sensitizing Tumor Cells by Targeting Death Receptor Signaling Inhibitors
- Ceramide, Ceramidase, and FasL Gene Therapy in Prostate Cancer
- Gene Therapy Targeting Receptor-Mediated Cell Death to Cancers
- Combination of Chemotherapy and Death Ligands in Cancer Therapy.